Medical Supplies & Equipment Home

>

Other

>

All items

>

Invega Sustenna 150 mg Injection - Long-Acting Antipsychotic for Schizophrenia

Invega Sustenna 150 mg Injection - Long-Acting Antipsychotic for Schizophrenia - Image 1 of 2
Invega Sustenna 150 mg Injection - Long-Acting Antipsychotic for Schizophrenia - Image 2 of 2

Invega Sustenna 150 mg Injection - Long-Acting Antipsychotic for Schizophrenia

$
385.87

excl. GST each

Enter the quantity you'd like to find a price that's right for you.

Total:

$385.87

Please note: Item is out of stock. Estimated dispatch 7 days from date of order.

Calculate shipping

Invega Sustenna 150 mg Injection

Invega Sustenna 150 mg Injection is a long-acting antipsychotic medication used primarily for the treatment of schizophrenia. It contains paliperidone, which helps in managing symptoms such as hallucinations and delusions. This injection is administered under the supervision of a healthcare professional and is known for its efficacy in maintaining a consistent level of medication in the body.

Key Features
  • Long-acting injectable formulation
  • Used for schizophrenia and schizoaffective disorder
  • Administered monthly
Technical Specifications
  • Active Ingredient Paliperidone
  • Dosage 150 mg
Application or Use Case

Primarily used for the treatment of schizophrenia and schizoaffective disorder.

Typical User/Industry Profile

Patients diagnosed with schizophrenia or schizoaffective disorder.

About the Brand

Invega Sustenna is a product of Janssen Pharmaceuticals, a leader in the field of mental health medications. Known for their innovative solutions, Janssen has been at the forefront of developing treatments that improve the quality of life for individuals with mental health conditions.

benefit

Free Shipping on Orders $399+ (Ex. Rural - Volumetric)

benefit

Easy Returns

benefit

Online Support 24/7

benefit

Volume Price Matching

newsletter background

Join Our Newsletter

Exclusive discounts & promotions.